Originally published July 30 2005
Vitamin D may prolong life of prostate cancer patients
by Mike Adams, the Health Ranger, NaturalNews Editor
A potent form of vitamin D developed at Oregon Health and Science University may extend the lives of dying prostate cancer patients, according to a new study.
A potent form of vitamin D developed at Oregon Health and Science University may extend the lives of dying prostate cancer patients, according to a new study.
It included 250 men with advanced tumors that continued to grow despite treatment with radiation or surgery and subsequent drug therapy.
Currently, such patients receive the chemotherapy drug docetaxel, which extends their lives for an average of 16 months.
The new study found that adding the experimental vitamin pill DN-101 to that chemotherapy extended survival by an average of 7.1 months, the Associated Press reported.
While this study indicated that DN-101 prolongs the life of these prostate cancer patients, it wasn't large enough to prove that DN-101 is ready for market.
That will require a study of about 600 patients, the AP reported.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml